In addition, HSPH1 mutation enhanced chemosensitivity to drugs, such as oxaliplatin and 5-fluorouracil, and improved prognosis in colorectal cancers with microsatellite instability (Dorard et al., 2011). This evidence concerns the gene HSPH1 and colorectal cancer.